May 7, 2025
Luminor DCB, now in Japan
Barcelona, Spain – iVascular…
February 20, 2025
Exceptional Long-Term Outcomes of iVascular Angiolite Drug-Eluting Stent in Real-Life Clinical Practice
Barcelona— iVascular is pleased…
November 11, 2024
iVascular initiates OPAL study with its new embolic liquid Amber
iVascular announces the initiation…
July 25, 2024
Exceptional Navigability of iVascular essential pro drug-coated balloon for the treatment of coronary in-stent restenosis
Barcelona, June 19, 2024…
July 25, 2024
The first results of the SOL Japan Study highlight the excellent efficacy of Luminor DCB in the Japanese population
iVascular is pleased to…
April 17, 2024
Research Chair in Surgery at the UAB Faculty of Medicine
We are thrilled to…
January 18, 2024
iVascular announces first enrollment in new ANGIODAPT trial, an RCT of abbreviated DAPT post-stent implantation in all-comers
First patient enrolled in…
January 18, 2024
LUMIFOLLOW preliminary 1 year outcomes revealed at PVI 2023
Luminor DCB has confirmed…
January 11, 2024
BIBLIOS STUDY FULL COHORT RESULTS on BTK lesions presented at PVI
iVascular presented Luminor DCB…
October 20, 2022
BIBLIOS study first results on BTK lesions presented at linc
iVascular presented for the…
July 26, 2022
RANGO Registry new 3-year follow up outcomes
After the positive pre-clinical…
